S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
ASX:IHL

Incannex Healthcare Limited (IHL.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.05
MA: A$0.05
A$0.05
52-Week Range N/A
Volume627,285 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's therapeutic products in clinical trials include IHL-42X for obstructive sleep apnea; IHL-216A for traumatic brain injury; IHL-675A for sepsis associated acute respiratory distress syndrome; and IHL-493C for temporomandibular joint dysfunction. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea. Incannex Healthcare Limited has partnership with Monash University to conduct clinical trial. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited is based in Melbourne, Australia.

MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 4 2570 3805
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$609,429.00
Book ValueA$0.00 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive IHL News and Ratings via Email

Sign-up to receive the latest news and ratings for IHL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Incannex Healthcare Limited (IHL.AX) (ASX:IHL) Frequently Asked Questions

What stocks does MarketBeat like better than Incannex Healthcare Limited (IHL.AX)?

Wall Street analysts have given Incannex Healthcare Limited (IHL.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Incannex Healthcare Limited (IHL.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Incannex Healthcare Limited (IHL.AX)'s earnings last quarter?

Incannex Healthcare Limited (IHL.AX) (ASX:IHL) posted its quarterly earnings data on Wednesday, February, 27th. The company reported $0.00 earnings per share (EPS) for the quarter.
View Incannex Healthcare Limited (IHL.AX)'s earnings history
.

Who are some of Incannex Healthcare Limited (IHL.AX)'s key competitors?

What other stocks do shareholders of Incannex Healthcare Limited (IHL.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Incannex Healthcare Limited (IHL.AX) investors own include Tahoe Resources (TAHO) and Hertz Global (HTZ).

Who are Incannex Healthcare Limited (IHL.AX)'s key executives?

Incannex Healthcare Limited (IHL.AX)'s management team includes the following people:
  • Mr. Joel Bradley Latham, MD, CEO & Exec. Director
  • Dr. Sud Agarwal B.Sc., Chairman of Medical Advisory Board, Chief Medical Officer & Non-Exec. Director
  • Mr. John Michailidis, Chief Exec. Officer of IncannexTM
  • Mr. Glenn Fowles BBS, Company Sec.

What is Incannex Healthcare Limited (IHL.AX)'s stock symbol?

Incannex Healthcare Limited (IHL.AX) trades on the ASX under the ticker symbol "IHL."

How big of a company is Incannex Healthcare Limited (IHL.AX)?

Incannex Healthcare Limited (IHL.AX) has a market capitalization of $0.00 and generates $609,429.00 in revenue each year.

What is Incannex Healthcare Limited (IHL.AX)'s official website?

The official website for Incannex Healthcare Limited (IHL.AX) is impression.healthcare.

How can I contact Incannex Healthcare Limited (IHL.AX)?

The company can be reached via phone at 61 4 2570 3805.

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.